Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
bisphosphocin nu-3 (3 trials)
Diabetes Mellitus (Phase 2)
Diabetic Foot (Phase 2)
Trials (3 total)
Trial APIs (1 total)